At a glance
- Originator Nonindustrial source
- Class Antifungals; Antineoplastics; Lactones; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 13 Nov 2001 No-Development-Reported for Mycoses in USA (Unknown route)
- 08 Dec 1997 Preclinical development for Mycoses in USA (Unknown route)
- 29 Sep 1997 New profile